CYTL1 and gastric adenocarcinoma: We applied bioinformatics methods to identify the expression pattern of STAD patients; although CYTL1 was low expressed in STAD (relative to normal samples), high expression of CYTL1 often predicted poor prognosis (including OS and DSS).